학술논문

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Document Type
Article
Author
Stambler, Bruce SCamm, A JohnAlings, MarcoDorian, PaulHeidbuchel, HeinHoutgraaf, JacoKowey, Peter RMerino, Jose LMondésert, BlandinePiccini, Jonathan PPokorney, Sean DSager, Philip TVerma, AtulWharton, J MarcusBharucha, David BPlat, FrancisShardonofsky, SilviaChen, MichaelIp, James EIp, James EJones, AlonzoStambler, Bruce SSchleinkofer, David EWinters, StephenLam, WilsonGoldstein, RobertDor, Isaac DorTalwar, SandeepO'Neill, Padraig GKoren, Michael JBeinart, Sean CAmbati, SrivaniMazer, Sean PKinn, Robert MRoy, KarineManshadi, RaminKuk, RichardVerma, AdityaPhelan, TimothyStoian, Alexandru AEllenbogen, KennethJayachandran, J VijayConnelly, Terence PDaccarett, MarcosGandhi, GaurangMittal, SuneetAbdel-Wahab, AmirAugostini, RalphIp, John HSorrentino, DeniseRoux, Jean-FrancoisBrar, RamandeepKhoo, ClarenceBennett, MatthewLo, EricCoutu, BenoitSterns, LaurenceGreer, Gerald SGujja, PradeepGianfagna, Robert ASwarup, VijendraSogade, FelixWilton, StephenRuisi, ChristopherBarbera, SaverioBanchs, Javier E.Korley, VictoriaSchulze, ChristopherDamle, RogerHealey, Jeffrey SeanPandey, A ShekharAnderson, Jeffrey LVenkatachalam, K LNoseworthy, PeterMondésert, BlandineVerma, AtulFriars, Douglas GKambur, Thomas RLockwood, EvanMeininger, GlennOlsovsky, GregJones Sr, AlonzoGreer, GeraldMehta, RohitAkbar, SaleemSalman, MalikRama, BholaArora, RameshShah, DhirenkumarShah, RakeshCammarata, MichaelOwens, AndrewLudington, KatherineWharton, MarcusBagheri, MichaelKhan, MohammedCarr, Kenneth WarrenSiddique, SultanParvathaneni, SunthoshDevabhaktuni, SubodhMouhaffel, AssadMark, GeorgeDi Biase, LuigiRangappa, SunilMorton, JaredYarmohammadi, HiradKarim, AminMartinez Fleites, AldoNero, ThomasShafiq, QaiserCoutu, BenoitPandey, ShekharKhaykin, YaarivJoza, JacquelineGosselin, GilbertSkanes, AllenVyselaar, JohnSavard, DanielHeidbuchel, HeinXhaet, OlivierCatez, EmmanuelVijgen, JohanGodart, PascalCasado, RubenMairesse, GeorgesRossenbacker, TomHaemers, PeterHoffer, EtienneHausman, PierreVertes, AndrasDuray, GaborSzolnoki, ErzsebetCsanadi, ZoltanLakatos, FerencAlings, MarcoDorman, ReinhartTuininga, Y SJansen, WVelthuis, Sebastiaanvan Bemmel, BBech, Gerhard Jan WillemPisters, RonValk, SuzanneRomer, TjeerdLuermans, JustinBeelen, Driekvan Eck, MartijnHoutgraaf, JacoVet, ThijsShellings, DirkOosterhof, TMiekus, PawelBebenek, WaldemarBielecka-Dabrowa, AgataGniot, JacekZmuda, WitoldKasprzak, MichalBalak, WojciechPtaszynski, PawelNowak, JacekProkopczuk, JanuszPrzybylski, AndrzejWozniak-Skowerska, IwonaDerejko, PawelCzarnecka, DanutaJanas, AdamMerino Llorens, Jose LuisTercedor, LuisIniguez Romo, AndresRuiz Granell, RicardoGonzalez Juanatey, Jose RamonPascual-Figal, DomingoMartinez-Selles, ManuelAnguera Camos, IgnacioIbanez Criado, AliciaMatrinez Basterra, JavierIzquierdo, AlvaroRivas Gandara, NuriaAlegret Colome, Josep MPerez Diez, DiegoMartínez Hervás, Miguel ÁngelMedina, MariaSegura Saint-Gerons, Jose MaríaPedrote Leal, AlonsoFernandez Lozano, IgnacioQuesada, AurelioGuerra Ramos, JoseSarrias, AxelRamos Maqueda, JavierMansourati, JacquesDefaye, PascalGuedon-Moreau, LaurenceMilhem, AntoineDe Guillebon, MaximeChevalier, PhilippeBadoz, MarcKriatselis, CharalamposSimonis, GregorLewalter, ThorstenZarse, MarkusWilke, AndreasKraemer, FabianAl-Zoebi, Ayham
Source
The Lancet; July 2023, Vol. 402 Issue: 10396 p118-128, 11p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Etripamil is a fast-acting, intranasally administered calcium-channel blocker in development for on-demand therapy outside a health-care setting for paroxysmal supraventricular tachycardia. We aimed to evaluate the efficacy and safety of etripamil 70 mg nasal spray using a symptom-prompted, repeat-dose regimen for acute conversion of atrioventricular-nodal-dependent paroxysmal supraventricular tachycardia to sinus rhythm within 30 min.